HIV reservoir dynamics according to the timing of antiretroviral therapy initiation or modification
- PMID: 41819373
- DOI: 10.1016/j.idnow.2026.105264
HIV reservoir dynamics according to the timing of antiretroviral therapy initiation or modification
Abstract
Introduction: HIV reservoir is the main barrier to HIV cure but its size dynamics on antiretroviral therapy (ART) in various clinical settings is poorly characterized.
Methods: Responders to a dolutegravir-based regimen (DBR) enrolled in the DRONE study were analyzed for longitudinal total HIV DNA and immune activation biomarkers (sCD14, sCD163, IL-6, IP-10).
Results: Overall, 169 participants were allocated to various groups: ART-naive acute infections (AI, n = 20) or chronic infections (CI, n = 21), and ART-treated individuals in virological success (VS, n = 116) or failure (VF, n = 12). HIV DNA significantly decreased at W48 of successful DBR in the AI (median: -1.3log10copies/million PBMCs), CI (-0.6), and VF (-0.5) groups, but not in the VS group. Activation biomarkers decreased on DBR only for individuals with ongoing HIV replication at baseline.
Conclusion: Successful DBR was associated with rapid HIV DNA decline in ART-naive and ART-failing individuals but not in the context of ART switch.
Keywords: Acute infection; HIV DNA; HIV reservoir; Inflammation; Integrase inhibitor.
Copyright © 2026 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
LinkOut - more resources
Full Text Sources
